Functional 5-HT receptors in human occipital artery

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 369, Issue 4, 2004, Pages 391-401

  Verheggen, Raphaela ^a   Meier, Andreas ^a   Werner, Inga ^a   Wienekamp, Andreas ^a   Kruschat, Thomas ^a   Brattelid, Trond ^b   Levy, Finn Olav ^b   Kaumann, Alberto ^c  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

5 HT receptor mRNA; 5 HT1B and 5 HT2A receptors; 5 Hydroxytryptamine; Contraction; Human occipital artery; Ketanserin sensitive relaxation; Nitro L arginine

Indexed keywords

1 (1 METHYL 5 INDOLYL) 3 (3 METHYL 5 ISOTHIAZOLYL)UREA; 1 METHYL 3 INDOLECARBOXYLIC ACID [1 [2 (METHYLSULFONYLAMINO)ETHYL] 4 PIPERIDINYLMETHYL] ESTER; 2,3,6,7 TETRAHYDRO 1' METHYL 5 [[2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL) 4 BIPHENYLYL]CARBONYL]SPIRO[FURO[2,3 F]INDOLE 3,4' PIPERIDINE]; 3 [2 [2 (4 METHYL 1 PIPERIDINYL)ETHYL] 1 PYRROLIDINESULFONYL]PHENOL; 3 [4 (3 CHLOROPHENYL) 1 PIPERAZINYL] 1,1 DIPHENYL 2 PROPANOL; KETANSERIN; MESSENGER RNA; PRAZOSIN; SEROTONIN; SEROTONIN 1B ANTAGONIST; SEROTONIN 1B RECEPTOR; SEROTONIN 1D ANTAGONIST; SEROTONIN 1D RECEPTOR; SEROTONIN 2 ANTAGONIST; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN 2B RECEPTOR; SEROTONIN 2B RECEPTOR ANTAGONIST; SEROTONIN 4 ANTAGONIST; SEROTONIN 4 RECEPTOR; SEROTONIN 4A RECEPTOR; SEROTONIN 4B RECEPTOR; SEROTONIN 4G RECEPTOR; SEROTONIN 4I RECEPTOR; SEROTONIN 7 RECEPTOR; SEROTONIN 7AB RECEPTOR; SEROTONIN 7D RECEPTOR; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADULT; AGED; ARTERY CONSTRICTION; ARTERY DILATATION; ARTICLE; BRAIN ARTERY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG MEGADOSE; DRUG SELECTIVITY; FEMALE; HUMAN; HUMAN TISSUE; LOW DRUG DOSE; MALE; OCCIPITAL ARTERY; PHARMACOLOGICAL BLOCKING; RECEPTOR BLOCKING; RNA ANALYSIS; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CEREBRAL ARTERIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE RELAXATION; OCCIPITAL LOBE; RECEPTORS, SEROTONIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 2142654974     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-004-0878-9     Document Type: Article

References (33)

1. 4(b) receptors have nearly identical pharmacology and are both expressed in human atrium and ventricle. Naunyn-Schmiedeberg's Arch Pharmacol 363:146-160
2. Bogduk N (1981) The anatomy of occipital neuralgia. Clin Exp Neurol 17:167-184
3. (i). Naunyn-Schmiedeberg's Arch Pharmacol (in press)
4. Cocks TM, Arnold PJ (1992) 5-Hydroxytryptamine (5-HT) mediates potent relaxation in the sheep isolated pulmonary vein via activation of 5-HT4 receptors. Br J Pharmacol 107:591-596
5. 2B receptor antagonist. J Med Chem 38: 855-857
6. Fozard JR, Kalkman HO (1994) 5-Hydroxytryptamine (5-HT) and the initiation of migraine: new perspectives. Naunyn-Schmiedeberg's Arch Pharmacol 350:225-229
7. 2B receptors. Br J Pharmacol 130:692-698
8. 4 receptor: use of a novel antagonist. Br J Pharmacol 108:106P
9. 7 receptor antagonist. Br J Pharmacol 130:539-548
10. 1D receptor subtypes. Trends Pharmacol Sci 17:103-105
11. Haugen G, Mellembakken J, Stray-Pedersen S (1997) Characterization of the vasodilatatory response to serotonin in human umbilical arteries perfused in vitro. The influence of the endothelium. Early Hum Dev 47:185-193
12. 7) receptor isoforms in human and rat produced by alternative splicing: species differences due to altered intron-exon organization. J Neurochem 68:1372-1381
13. Hoyer D, Clarke DE, Fozard JR, Hartig PPA, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PPA (1994) International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157-203
14. 3 receptor subtypes. Eur J Pharmacol 414:23-30
15. 4 receptors by GR113808. Br J Pharmacol 110:1172-1174
16. Kaumann AJ, Parssons AA, Brown AM (1993) Human arterial constrictor serotonin receptors. Cardiovasc Res 27:2094-2103
17. 1Dβ receptors. Circulation 90:1141-1153
18. Kerr FWL (1961) Structural relation of the trigeminal spinal tract to upper cervical roots in the solitary nucleus in the cat. Exp Neurol 4:134-148
19. 7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution. Naunyn-Schmiedeberg's Arch Pharmacol 363: 620-632
20. Kuhn WF, Kuhn SC, Gilberstadt H (1997) Occipital neuralgia: clinical recognition of a complicated headache. A case series and literature review. J Orofac Pain 11:158-165
21. 7 receptors mediating direct relaxation in Cynomolgus monkey isolated jugular veins. Br J Pharmacol 117:926-930
22. 2B receptor: molecular modelling and site directed mutagenesis. J Biol Chem 277:10170-10178
23. 1D receptors. Naunyn-Schmiedeberg's Arch Pharmacol 356:312-320
24. Purdy RE, Murray DL, Stupecky GL (1987) Receptors for 5-hydroxytryptamine in rabbit blood vessels: activation of alpha adrenoceptors in rabbit thoracic aorta. J Pharmacol Exp Ther 240:535-541
25. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory, New York
26. 1D subtype. J Pharmacol Exp Ther 252:387-395
27. 2B receptors: an early step in the generation of migraine headache? Eur J Neurosci 8:959-967
28. Ullmer C, Schmuck K, Kalkman HO, Lübbert H (1995) Expression of serotonin receptor mRNAs in blood vessels. FEBS Lett 370:215-221
29. 2A receptors in the contraction of human temporal artery by 5-hydroxytryptamine and related drugs. Br J Pharmacol 117:283-289
30. 1B receptor-mediated contractions in human temporal artery: evidence from selective antagonists and 5-HT receptor mRNA expression. Br J Pharmacol 124:1345-1354
31. Verheggen R, Meier A, Kruschat T, Kaumann AJ (2000) Human occipital artery: an experimental model for 5-hydroxytryptamine-evoked contraction and relaxation. Naunyn-Schmiedeberg's Arch Pharmacol 361 [Suppl R29]:102
32. Verheggen R, Bumann K, Kaumann AJ (2002) BIBN4096BS is a potent competitive antagonist of the relaxant effects of α-CGRP on human temporal artery: comparison with CGRP (8-37). Br J Pharmacol 136:120-126
33. 2B receptor, evidence for species differences. J Pharmacol Exp Ther 276:720-727